ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
1.445
+0.075 (5.47%)
Jul 24, 2026, 5:24 PM CET
STO:EXPRS2 Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 21.84 | 47.56 | 81.54 | 57.6 | 110.97 | 37.11 |
Short-Term Investments | - | - | - | - | - | 203.54 |
Cash & Short-Term Investments | 21.84 | 47.56 | 81.54 | 57.6 | 110.97 | 240.65 |
Cash Growth | -62.34% | -41.68% | 41.57% | -48.10% | -53.89% | 125.26% |
Accounts Receivable | 1.03 | 1.19 | 1.19 | 0.95 | 0.83 | 1.62 |
Other Receivables | 9.84 | 7.21 | 11.48 | 9.61 | 9.97 | 5.48 |
Total Trade Receivables | 10.87 | 8.4 | 12.67 | 10.56 | 10.79 | 7.11 |
Other Current Assets | 10.31 | 1.58 | 1.15 | 0.52 | 10.18 | 0.48 |
Total Current Assets | 43.02 | 57.53 | 95.36 | 68.67 | 131.94 | 146.46 |
Net Property, Plant & Equipment | 0.27 | 0.47 | 1.54 | 1.77 | 0.91 | 1.21 |
Other Intangible Assets | 1.41 | 1.5 | 2.08 | 2.47 | 2.95 | 3.14 |
Long-Term Investments | 4.39 | 4.34 | 4.62 | 4.46 | 0.03 | 0.02 |
Other Long-Term Assets | 1.32 | 1.27 | 1.32 | 1.32 | 1.53 | 1.12 |
Total Assets | 50.4 | 65.11 | 104.91 | 78.69 | 137.36 | 151.96 |
Accounts Payable | 1.64 | 4.04 | 8.47 | 1.84 | 12.15 | 1.69 |
Short-Term Debt | 0.52 | 0.5 | 0.36 | 0.28 | 1.76 | 1.92 |
Other Current Liabilities | 20.81 | 23.71 | 29.42 | 9.27 | 17.51 | 3.86 |
Total Current Liabilities | 22.96 | 28.26 | 38.25 | 11.38 | 31.43 | 7.46 |
Other Long-Term Liabilities | 1.02 | 1.16 | 1.87 | 1.95 | 2.61 | 4.15 |
Total Long-Term Liabilities | 0.73 | 0.85 | 1.44 | 1.44 | 2 | 3.48 |
Total Liabilities | 23.69 | 29.11 | 39.68 | 12.82 | 33.43 | 10.94 |
Common Stock | 15.69 | 15.69 | 11.82 | 5.71 | 4.18 | 3.46 |
Additional Paid-in Capital | 172.72 | 207.08 | 269.62 | 529.75 | 338.65 | 266.24 |
Retained Earnings | -161.99 | -187.08 | -216.63 | -470.1 | -239.5 | -129.36 |
Shareholders' Equity | 26.42 | 35.69 | 64.8 | 65.36 | 103.33 | 140.35 |
Total Liabilities & Equity | 50.4 | 65.11 | 104.91 | 78.69 | 137.36 | 151.96 |
Total Debt | 0.52 | 0.5 | 0.36 | 0.28 | 1.76 | 1.92 |
Net Cash (Debt) | 21.33 | 47.05 | 81.18 | 57.32 | 109.21 | 238.73 |
Net Cash Growth | -54.68% | -42.04% | 41.62% | -47.51% | -54.25% | 127.49% |
Net Cash Per Share | 1.57 | 16.54 | 48.01 | 49.70 | 124.49 | 326.57 |
Book Value | 26.42 | 35.69 | 64.8 | 65.36 | 103.33 | 140.35 |
Book Value Per Share | 1.94 | 12.54 | 38.32 | 56.67 | 117.78 | 191.99 |
Tangible Book Value | 25.01 | 34.18 | 62.72 | 62.89 | 100.37 | 137.21 |
Tangible Book Value Per Share | 1.84 | 12.02 | 37.09 | 54.53 | 114.42 | 187.69 |